Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01E PROTEIN KINASE INHIBITORS
L01EB Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors
L01EB10 Mobocertinib
D11969 Mobocertinib succinate (JAN) <US>
Drug groups [BR:br08330]
Antineoplastic
DG01918 Tyrosine kinase inhibitor
DG01917 Receptor tyrosine kinase inhibitor
DG03148 Mobocertinib
D11969 Mobocertinib succinate
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
DG03148 Mobocertinib
D11969 Mobocertinib succinate
Target-based classification of drugs [BR:br08310]
Protein kinases
Receptor tyrosine kinases (RTK)
EGFR family
EGFR* [HSA_VAR:1956v2]
D11969 Mobocertinib succinate (JAN) <US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D11969
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D11969
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D11969
Pharmacogenomic biomarkers [br08341.html]
Somatic variations in targeted cancer therapies
D11969
Drug groups [BR:br08330]
Antineoplastic
DG01918 Tyrosine kinase inhibitor
DG01917 Receptor tyrosine kinase inhibitor
DG03148 Mobocertinib
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
DG03148 Mobocertinib
LinkDB
KCF data
ATOM 51
1 C8y C 19.3101 -20.0765
2 C8y C 20.5691 -19.3770
3 C8x C 20.5691 -17.9781
4 C8y C 19.3800 -17.2786
5 C8y C 18.1210 -17.9781
6 C8x C 18.1210 -19.3770
7 N1b N 16.9319 -17.2786
8 C8y C 16.9319 -15.8797
9 N5x N 18.1909 -15.1802
10 C8x C 18.1909 -13.7813
11 C8y C 16.9319 -13.0818
12 C8y C 15.7428 -13.7813
13 N5x N 15.7428 -15.1802
14 C8y C 14.5537 -13.0818
15 O2a O 19.3800 -15.8797
16 C1a C 20.5691 -15.1802
17 C8x C 14.2739 -11.6829
18 N4y N 12.8750 -11.5430
19 C8y C 12.3154 -12.8020
20 C8y C 13.2947 -13.7113
21 C8x C 10.9864 -13.2217
22 C8x C 10.6367 -14.5507
23 C8x C 11.6859 -15.5299
24 C8x C 13.0149 -15.1103
25 C1a C 12.1755 -10.2839
26 N1c N 21.7582 -20.0765
27 C1a C 21.7582 -21.4754
28 C1b C 22.9473 -19.4470
29 N1b N 19.3101 -21.4754
30 C5a C 18.1210 -22.1749
31 C2b C 16.8620 -21.4754
32 O5a O 18.1210 -23.5738
33 C1b C 24.2064 -20.1464
34 N1c N 25.3955 -19.4470
35 C1a C 26.5846 -20.1464
36 C1a C 25.3955 -18.0480
37 C2a C 15.6729 -22.1749
38 C7a C 16.9319 -11.6829
39 O7a O 15.7428 -10.9134
40 O6a O 18.1210 -10.9134
41 C1c C 15.7428 -9.5145
42 C1a C 14.4838 -8.8150
43 C1a C 16.9319 -8.8150
44 C6a C 26.3900 -12.8800
45 C1b C 27.6024 -13.5800
46 O6a O 25.1776 -13.5800
47 C1b C 28.7979 -12.8896
48 C6a C 29.9853 -13.5751
49 O6a O 31.1765 -12.8871
50 O6a O 29.9855 -14.9798
51 O6a O 26.3900 -11.4800
BOND 53
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 5 7 1
8 7 8 1
9 8 9 2
10 9 10 1
11 10 11 2
12 11 12 1
13 12 13 2
14 8 13 1
15 12 14 1
16 4 15 1
17 15 16 1
18 14 17 2
19 17 18 1
20 18 19 1
21 19 20 2
22 14 20 1
23 19 21 1
24 21 22 2
25 22 23 1
26 23 24 2
27 20 24 1
28 18 25 1
29 2 26 1
30 26 27 1
31 26 28 1
32 1 29 1
33 29 30 1
34 30 31 1
35 30 32 2
36 28 33 1
37 33 34 1
38 34 35 1
39 34 36 1
40 31 37 2
41 11 38 1
42 38 39 1
43 38 40 2
44 39 41 1
45 41 42 1
46 41 43 1
47 44 45 1
48 44 46 1
49 45 47 1
50 47 48 1
51 48 49 1
52 48 50 2
53 44 51 2
